ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $7,400,000 | +8.2% | 2,500,000 | -41.9% | 0.40% | -21.8% |
| Q4 2018 | $6,837,000 | -7.1% | 4,300,000 | +115.0% | 0.52% | +17.2% |
| Q3 2018 | $7,360,000 | -35.0% | 2,000,000 | -50.0% | 0.44% | -40.2% |
| Q2 2018 | $11,320,000 | -29.0% | 4,000,000 | -6.9% | 0.74% | -39.4% |
| Q1 2018 | $15,938,000 | +248.0% | 4,296,000 | +321.2% | 1.22% | +125.7% |
| Q3 2017 | $4,580,000 | – | 1,020,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |